We are live on ! Find out more
GWCM

Godshalk Welsh Capital Management Portfolio holdings

AUM $172M
1-Year Est. Return 16.03%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+16.03%
3 Year Est. Return
+54.69%
5 Year Est. Return
+73.83%
10 Year Est. Return
+285.54%
AUM
$137M
AUM Growth
+$1.65M
Cap. Flow
-$9.64M
Cap. Flow %
-7.03%
Top 10 Hldgs %
28.94%
Holding
122
New
5
Increased
6
Reduced
88
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 19.5%
2 Healthcare 15.98%
3 Consumer Staples 11.7%
4 Financials 11.36%
5 Consumer Discretionary 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
26
Bank of America
BAC
$448B
$1.66M 1.21%
50,125
-1,120
-2% -$38.6K
WM icon
27
Waste Management
WM
$90.7B
$1.63M 1.19%
10,360
-355
-3% -$57.1K
JPM icon
28
JPMorgan Chase
JPM
$962B
$1.55M 1.13%
11,575
-259
-2% -$32.8K
ZTS icon
29
Zoetis
ZTS
$31.1B
$1.54M 1.13%
10,525
-275
-3% -$40.7K
UNH icon
30
UnitedHealth
UNH
$365B
$1.53M 1.11%
2,880
-113
-4% -$59.9K
PGX icon
31
Invesco Preferred ETF
PGX
$3.76B
$1.47M 1.07%
131,508
-3,400
-3% -$39.3K
BDX icon
32
Becton Dickinson
BDX
$49.4B
$1.47M 1.07%
5,765
-292
-5% -$68.9K
WTRG icon
33
Essential Utilities
WTRG
$11.4B
$1.47M 1.07%
30,711
-511
-2% -$23.1K
VIG icon
34
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.41M 1.03%
9,255
-1,200
-11% -$179K
AMT icon
35
American Tower
AMT
$79B
$1.37M 1%
6,475
+35
+0.5% +$7.29K
PFE icon
36
Pfizer
PFE
$152B
$1.36M 0.99%
26,475
-3,285
-11% -$157K
BSV icon
37
Vanguard Short-Term Bond ETF
BSV
$45.6B
$1.31M 0.96%
17,433
-8,668
-33% -$650K
IEFA icon
38
iShares Core MSCI EAFE ETF
IEFA
$195B
$1.3M 0.95%
21,137
-1,248
-6% -$73.5K
TGT icon
39
Target
TGT
$69.2B
$1.3M 0.95%
8,715
-53
-0.6% -$8.31K
GOOG icon
40
Alphabet (Google) Class C
GOOG
$4.19T
$1.3M 0.95%
14,600
-40
-0.3% -$3.82K
MCD icon
41
McDonald's
MCD
$194B
$1.27M 0.92%
4,810
-116
-2% -$30.6K
ABBV icon
42
AbbVie
ABBV
$442B
$1.2M 0.87%
7,406
-244
-3% -$37.4K
TJX icon
43
TJX Companies
TJX
$172B
$1.17M 0.85%
14,650
-620
-4% -$45.8K
CVS icon
44
CVS Health
CVS
$120B
$1.15M 0.84%
12,300
-430
-3% -$41.5K
PYPL icon
45
PayPal
PYPL
$50.5B
$1.14M 0.83%
16,058
-425
-3% -$34K
BIV icon
46
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$1.08M 0.79%
14,542
-4,636
-24% -$344K
CI icon
47
Cigna
CI
$72.4B
$1.07M 0.78%
3,215
-15
-0.5% -$4.75K
COP icon
48
ConocoPhillips
COP
$151B
$1.06M 0.77%
8,950
-684
-7% -$83.1K
VLO icon
49
Valero Energy
VLO
$93.3B
$1.04M 0.76%
8,225
-519
-6% -$65.1K
MDLZ icon
50
Mondelez International
MDLZ
$78.9B
$1.04M 0.76%
15,562
-548
-3% -$34.6K

Similar funds

Godshalk Welsh Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Godshalk Welsh Capital Management held 122 positions worth $137M, up 1.2% from $135M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Godshalk Welsh Capital Management withdrew a net $9.64M in Q4 2022, closing 9 positions and reducing 88 holdings. Its most notable exit was Southern Company, an estimated $274K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Godshalk Welsh Capital Management opened a new position in Elevance Health worth $333K.

  • Godshalk Welsh Capital Management's largest Q4 2022 buy was Elevance Health: 650 shares worth $333K.
  • Godshalk Welsh Capital Management added most to iShares Core Moderate Allocation ETF in Q4 2022, an estimated $144K increase.
  • Godshalk Welsh Capital Management's biggest Q4 2022 reduction was Globus Medical, cutting an estimated $1.76M.
  • Godshalk Welsh Capital Management fully exited Southern Company in Q4 2022, selling an estimated $274K.
  • Godshalk Welsh Capital Management's ten largest holdings make up 29% of its $137M portfolio in Q4 2022.
  • Godshalk Welsh Capital Management opened 5 new positions and closed 9 in Q4 2022.
  • Godshalk Welsh Capital Management's portfolio value rose 1.2% quarter-over-quarter to $137M.

Based on Godshalk Welsh Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.